Usha Martin Limited (NSE:USHAMART)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	112,060	102,591	97,015	65,260	40,988	10,087
Market Cap Growth	5.75%	5.75%	48.66%	59.22%	306.34%	106.88%
Enterprise Value	113,503	105,333	99,148	68,553	44,053	14,498
Last Close Price	368.15	334.67	313.24	209.53	129.30	31.77
PE Ratio	27.51	25.18	22.88	18.64	14.07	6.74
PS Ratio	3.23	2.95	3.01	2.00	1.53	0.48
PB Ratio	4.07	3.73	4.07	3.21	2.42	0.72
P/TBV Ratio	4.17	3.82	4.19	3.31	2.51	0.75
P/FCF Ratio	-	57.93	58.37	94.23	38.15	5.71
P/OCF Ratio	-	24.33	21.86	25.94	25.85	4.72
EV/Sales Ratio	3.27	3.03	3.07	2.10	1.64	0.69
EV/EBITDA Ratio	18.33	17.81	16.63	13.18	11.15	5.01
EV/EBIT Ratio	21.69	20.84	18.81	14.93	13.20	6.32
EV/FCF Ratio	64.09	59.47	59.65	98.98	41.00	8.21
Debt / Equity Ratio	0.15	0.15	0.15	0.21	0.24	0.38
Debt / EBITDA Ratio	0.69	0.69	0.60	0.79	1.03	1.80
Debt / FCF Ratio	2.35	2.35	2.19	6.01	3.83	3.00
Asset Turnover	0.98	0.98	1.00	1.12	1.00	0.81
Inventory Turnover	1.79	1.79	1.74	2.03	1.92	1.74
Quick Ratio	1.30	1.30	1.29	1.05	0.97	0.78
Current Ratio	2.86	2.86	2.91	2.47	2.26	1.72
Return on Equity (ROE)	15.82%	15.82%	19.20%	18.79%	18.77%	11.67%
Return on Assets (ROA)	8.93%	8.93%	10.27%	9.84%	7.80%	5.55%
Return on Capital (ROIC)	10.68%	10.68%	12.68%	12.58%	10.31%	7.50%
Return on Capital Employed (ROCE)	16.60%	16.60%	19.40%	19.30%	16.40%	12.80%
Earnings Yield	3.64%	3.97%	4.37%	5.37%	7.11%	14.83%
FCF Yield	1.58%	1.73%	1.71%	1.06%	2.62%	17.51%
Dividend Yield	0.79%	0.90%	0.88%	1.19%	1.55%	-
Payout Ratio	20.57%	20.57%	17.97%	17.41%	-	-
Buyback Yield / Dilution	0.01%	0.01%	-	-	-	-
Total Shareholder Return	0.80%	0.91%	0.88%	1.19%	1.55%	-

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.